Press Releases

Press Releases

    Date Title View
    03/15/21
    Summary ToggleHorizon Therapeutics plc Completes Acquisition of Viela Bio, Inc.
    PDF Version
    03/12/21
    Summary ToggleHorizon Therapeutics plc Named Number One Best Workplace in Biopharma
    PDF Version
    03/11/21
    Summary ToggleHorizon Therapeutics plc Named as One of the Best Workplaces in Ireland
    PDF Version
    02/26/21
    Summary ToggleHorizon Therapeutics plc to Present at the Cowen and Company 41st Annual Health Care Conference
    PDF Version
    02/25/21
    Summary ToggleHorizon Therapeutics plc Shines a Light on Rare Disease with the Launch of the #RAREis Photobooth to Benefit Make-A-Wish®
    PDF Version
    02/24/21
    Summary ToggleHorizon Therapeutics plc Reports Record Fourth-Quarter and Full-Year 2020 Financial Results; Announces Full-Year 2021 Guidance
    02/22/21
    Summary ToggleNew Survey Assessment Finds Debilitating Impact of Thyroid Eye Disease (TED) on Quality of Life Continues Well Beyond Acute Disease into Chronic Phase
    PDF Version
    02/03/21
    Summary ToggleHorizon Therapeutics plc to Release Fourth-Quarter and Full-Year 2020 Financial Results and Host Webcast on Feb. 24, 2021
    PDF Version
    02/01/21
    Summary ToggleHorizon Therapeutics plc to Acquire Viela Bio, Inc. to Significantly Expand Development Pipeline and Grow Rare Disease Medicine Portfolio
    PDF Version
    01/11/21
    Summary ToggleHorizon Therapeutics plc Provides Preliminary 2020 Financial Results, Exceeding Full-Year 2020 Net Sales and Adjusted EBITDA Guidance; Provides Update on TEPEZZA® (teprotumumab-trbw) Supply and New KRYSTEXXA® (pegloticase injection) Trials
    PDF Version
    Displaying 31 - 40 of 590 results